Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Sponsor: Canadian Cancer Trials Group
Utilization data will be collected from all patients entered on the trial at Canadian centres from the time of registration until death, removal from study, or completion of 10 years of follow-up. Protocol-specified health care utilization will be collected within trial case report forms, and will include study visits, radiographic assessments, laboratory investigations, and treatment administration. Resource utilization data collection will be supplemented by a self-administered resource utilization form (Stanford SMRC) to document non-protocol specified utilization. This will include hospitalizations (including days in hospital), emergency room visits, and non-protocol specified ambulatory visits.
This description comes directly from the study's public registry record.
Annette Hay · 613-533-6430 · ahay@ctg.queensu.ca
Always discuss trial participation with your own doctor first.
| BCCA - Vancouver | Vancouver, British Columbia, Canada | Recruiting |
| CancerCare Manitoba | Winnipeg, Manitoba, Canada | Recruiting |
| Regional Health Authority B, Zone 2 | Saint John, New Brunswick, Canada | Recruiting |
| Lakeridge Health Oshawa | Oshawa, Ontario, Canada | Not Yet Recruiting |
| Ottawa Hospital Research Institute | Ottawa, Ontario, Canada | Recruiting |
| The Jewish General Hospital | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05371808